| |
| |
|
| Insider
Information: |
Middleton Fred A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
593,164 |
|
|
Indirect Shares
|
7,544,680 |
|
|
| Direct
Value |
$3,059,061 |
|
|
|
Indirect Value
|
$6,091,574 |
|
|
| Total
Shares |
8,137,844 |
|
|
| Total
Value |
$9,150,635 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 2.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,217,224 |
8,434 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
287,786 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-06-14 |
4 |
B |
$3.00 |
$30,000 |
D/D |
10,000 |
297,786 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-09-01 |
4 |
B |
$1.37 |
$23,453 |
D/D |
17,119 |
314,905 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-09-15 |
4 |
B |
$1.38 |
$6,693 |
D/D |
4,850 |
319,755 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2011-11-21 |
4 |
B |
$6.50 |
$65,000 |
D/D |
10,000 |
10,000 |
3.92 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-12-16 |
4 |
B |
$3.16 |
$158,000 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-12-19 |
4 |
B |
$3.13 |
$75,383 |
D/D |
24,084 |
74,084 |
2.39 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-12-20 |
4 |
B |
$3.18 |
$2,913 |
D/D |
916 |
75,000 |
2.31 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2012-03-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
62,966 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2012-05-10 |
4 |
B |
$0.00 |
$0 |
I/I |
6,506,181 |
281,178 |
2.02 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2012-08-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11,471 |
45,564 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2012-11-30 |
4 |
B |
$1.53 |
$37,271 |
D/D |
24,360 |
76,072 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2012-12-06 |
4/A |
D |
$0.00 |
$0 |
D/D |
(98,596) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-01-24 |
4/A |
S |
$18.93 |
$9,465,000 |
D/D |
(500,000) |
882,562 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-07 |
4/A |
S |
$25.92 |
$662,515 |
D/D |
(25,560) |
1,361,762 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-07 |
4/A |
OE |
$2.69 |
$662,373 |
D/D |
79,031 |
1,372,169 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-11 |
4/A |
S |
$27.86 |
$9,721,775 |
D/D |
(348,951) |
559,453 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,133 |
67,966 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-15 |
4 |
AS |
$0.00 |
$0 |
D/D |
(200,000) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-18 |
4 |
AS |
$28.19 |
$4,745,234 |
D/D |
(165,411) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-19 |
4 |
AS |
$26.95 |
$2,306,831 |
D/D |
(84,589) |
416,083 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,433 |
70,399 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(557,845) |
174,898 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2013-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
88,072 |
0 |
- |
|
133 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
